Andecaliximab as Add-On Therapy to a Tumor Necrosis Factor Inhibitor and Methotrexate Regimen in Adults With Moderately to Severely Active Rheumatoid Arthritis
Clinical trial NCT02862574 · TERMINATED
Trial details
- NCT number
- NCT02862574
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-15
- Primary completion
- 2017-06-26
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.